doi: 10.1128/aac.01242-08 369 HuPHuangPChenMW
These medications include GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy, Rybelsus) and liraglutide, as well as dual GIP/GLP-1 receptor agonists like tirzepatide (Mounjaro, Zepbound)
The NHS picture is likely to evolve as the evidence base grows
And again, I just really want to emphasize that point that I think that a lot of focus has been on weight with these medications, but I encourage people to familiarize themselves with additional data around the cardiovascular benefits, reductions in things like heart attacks and strokes, reductions in fatty liver, protection of the kidneys and diabetes
The initiative builds on Amazons broader healthcare strategy, following its 2023 acquisition of One Medical and the launch of its online pharmacy in 2020